Curcumin adds spice to the debate: Lipid metabolism in liver disease

British Journal of Pharmacology

Volumn 157, Issue 8, 2009, Pages 1352-1353

  Graham, Annette ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

Adipogenesis; Fatty acids; Low density lipoprotein; Non alcoholic fatty liver disease; Peroxisome proliferator activated receptor ; Sterol regulatory element binding protein (SREBP 1c, SREBP 2); Triacylglycerol

Indexed keywords

CURCUMIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL;

ALCOHOLIC FATTY LIVER; APOPTOSIS; CELL PROLIFERATION; DRUG MECHANISM; GENE EXPRESSION; HUMAN; LIPID METABOLISM; LIPID STORAGE; LIVER CELL; LIVER DISEASE; LIVER FIBROSIS; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE CELL;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CURCUMIN; HEPATIC STELLATE CELLS; LIPID METABOLISM; LIPOPROTEINS, LDL; LIVER DISEASES; PPAR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEINS;

EID: 70350341461     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00335.x     Document Type: Note

References (11)

1. Chen A, Zheng S (2008). Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-kB and ERK signalling. Br J Pharmacol 153: 557-567.
2. Dou X, Fan C, Wo L, Yan J, Qian Y, Wo X et al. (2008). LDL receptor expression via the sterol regulatory element pathway in HepG2 cells. Planta Med 74: 1373-1379.
3. Friedman SL (2008). Hepatic stellate cells: protein, multi-functional, and enigmatic cells of the liver. Physiol Rev 88: 125-172.
4. Fu Y, Zheng S, Lin J, Ryerse J, Chen A (2008). Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidation stress and suppressing inflammation. Mol Pharmacol 73: 399-409.
5. Goel A, Kunnumakkara AB, Aggarwal BB (2008). Curcumin as 'cure-cumin': from kitchen to clinic. Biochem Pharmacol 75: 787-809.
6. Hazra S, Xiong S, Wang J, Rippe RA, Krishna V, Chatterjee K et al. (2004). Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem 279: 11392-11401.
7. Kang Q, Chen A (2009). Curcumin suppresses expression of low-density lipoprotein (LDL) receptor, leading to the inhibition of LDL-induced activation of hepatic stellate cells. Br J Pharmacol 157: 1354-1367.
8. Miyahara T, Schrum L, Rippe R, Xiong S, Yee HF Jr, Motomura, K et al. (2000). Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem 275: 35715-35722.
9. Peschel D, Koerting R, Nass N (2007). Curcumin induces changes in expression of genes involved in cholesterol homeostasis. J Nutr Biochem 18: 113-119.
10. Tsukamoto H (2005). Fat paradox in liver disease. Keio J Med 54: 190-192.
11. Tsukamoto H, She H, Hazra S, Cheng J, Miyahara T (2006). Anti-adipogenic regulation underlies hepatic stellate cell transdifferen-tiation. J Gastroenterol Hepatol 21: S102-S105.